Lectec Corp Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 7 of 7 Posts
AxoGen, Inc. Announces Closing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire Monday, May 14, 2018 10:19 AM EDT
AxoGen, Inc. today announced the closing of its previously announced underwritten public offering of 3,450,000 shares of its common stock, at a price to the public of $41.00 per share.
In this article: AXGN
Read
AxoGen - Chart Of The Day
Article By: Jim Van Meerten Thursday, November 30, 2017 2:41 PM EDT
Revenue expected to grow 44.10% this year and another 40.30% next year.
In this article: AXGN
Read
AxoGen Inc - Chart Of The Day
Article By: Jim Van Meerten Sunday, July 2, 2017 9:10 PM EDT
Since the Trend Spotter signaled a buy on 4/6 the stock gained 58.77%.
In this article: AXGN
Read
AxoGen - Chart Of The Day
Article By: Jim Van Meerten Tuesday, May 23, 2017 4:00 PM EDT
Revenue expected to grow 41.10% this year and another 36.50% next year.
In this article: AXGN
Read
How To Uncover Institutional Buying
Article By: Kevin Matras Wednesday, January 18, 2017 5:39 AM EDT
One of the best ways to find stocks on the move that are grabbing the attention of investors is to screen for stocks with increasing volume. As more investors buy the stock, the stock's price should go higher.
In this article: YELP, UCP, TBK, MAG, AXGN
Read
AxoGen Announces Proposed Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire Thursday, October 6, 2016 8:04 PM EDT
AxoGen, Inc., a global leader in innovative surgical solutions for peripheral nerve injuries, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.
In this article: AXGN
Read
Your Complete Guide To The Generic Drug Industry
Article By: Zacks Investment Research Wednesday, August 31, 2016 12:00 AM EDT
With some diseases, the range of safe concentration levels is incredibly narrow, which could make switching from name-brand to generic dangerous. But most generics are safe, and cheaper.
In this article: AGN, NVS, AKRX, MYL, PRGO, TEVA, AXGN, AMPH, GNRX
Read
1 to 7 of 7 Posts